
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
NIRF CRISPR/Cas9 KO Plasmid (h) | sc-403908 | 20 µg | $397.00 |
UHRF2 encodes NIRF, a RING finger E3 ubiquitin ligase and epigenetic regulator implicated in coupling ubiquitin signaling to chromatin-based control of gene expression. NIRF contains domains that support recognition of modified histones and DNA methylation states, linking it to maintenance of epigenetic information during DNA replication and to regulation of cell-cycle progression. Through ubiquitin-mediated proteostasis and chromatin remodeling, UHRF2 can influence DNA damage responses and transcriptional programs that govern proliferation and differentiation. Dysregulation of UHRF2/NIRF expression or activity has been associated with altered epigenetic landscapes observed in multiple cancer and neurobiology contexts, making it relevant for studies of genome stability and oncogenic signaling.
NIRF CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the UHRF2 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the UHRF2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the UHRF2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish NIRF protein expression.
This CRISPR knockout system enables efficient generation of UHRF2-deficient cell models for investigation of NIRF signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.